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Introduction
Metoprolol, a lipophilic cardioselective β1-adrenorecep-
tor antagonist, is widely used in the treatment of  hyper-
tension, angina pectoris and other cardiovascular diseas-
es. For oral administration it is available as immediate 
release (metoprolol tartrate) or controlled release tablet 
(metoprolol tartrate, metoprolol succinate). Metoprolol 
is almost completely absorbed from the gastrointesti-
nal tract. However, due to an extensive first pass effect, 
only 50% of  the dose reaches the systemic circulation. 
In the liver metoprolol is primarily metabolized by cyto-
chrome P450 2D6 (CYP2D6) into several metabolites. 
α-hydroxymetoprolol (Figure 1) is an active metabolite 
but possesses only around one tenth of  the β1-blocking 
activity of  metoprolol. Serum concentrations of  α-hy-
droxymetoprolol vary depending on age and on the oxi-
dation phenotype [1]. 
To determine metoprolol and its metabolite α-hy-
droxymetoprolol in serum for application in pharmaco-
kinetics we needed a convenient and accurate method 
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To determine metoprolol and its metabolite α-hydroxymetoprolol in human serum we validated 
a method on an LC system with an Exactive® Orbitrap mass spectrometer (Thermo Scientific) 
as detector and isotope-labelled metoprolol-d7 as internal standard. A simple sample preparation 
was used with water-acetonitrile (15:85, v/v) as precipitation reagent. This method has a chro-
matographic run time of  15 min and linear calibration curves in the  range of  5.0-250 µg/L for 
both metoprolol and α-hydroxymetoprolol. Validation showed the method to be accurate, with a 
good precision, selective and with a lower limit of  quantitation of  2.0 µg/L for metoprolol and 1.0 
µg/L for α-hydroxymetoprolol, respectively. This validated LC-Orbitrap MS analysis for metopro-
lol and α-hydroxymetoprolol can be used for application in human pharmacokinetics.
Keywords: metoprolol, α-hydroxymetoprolol, LC-MS, orbitrap mass spectrometer, pharmacokinetics.
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of  analysis. Numerous methods of  analysis have been 
reported for determination of  metoprolol, with and 
without metabolites, in human plasma, serum or urine, 
including high performance liquid chromatography with 
UV or fluorescence detection [2-7] and gas chromatog-
raphy with mass spectrometry [8]. In recent years several 
methods using liquid chromatography with tandem mass 
spectrometry have been published [9-15]. So far, liquid 
chromatography with high-resolution accurate mass 
spectrometry (MS) using Orbitrap technology has rarely 
been used for application in therapeutic drug monitoring 
and pharmacokinetics. The aim of  the present study was 
to validate a simple, sensitive LC–MS method to quantify 
metoprolol and α-hydroxymetoprolol in serum for appli-
cation in human pharmacokinetics. 
Materials and methods
Chemicals and reagents
Metoprolol tartrate, of  pharmaceutical quality (Ph 
Eur), was procured by Astra Zeneca (Zoetermeer, The 
Netherlands) and Fagron (Capelle aan den IJssel, The 
Netherlands). Metoprolol 1.0 mg/mL in methanol, 
α-hydroxymetoprolol 100 mg/L in methanol, and metop-
rolol-d7 hydrochloride 100 mg/L in methanol were ob-
tained from Campro Scientific (Veenendaal, The Nether-
lands). Methanol HPLC, gradient grade, and acetonitrile 
HPLC, gradient grade, were purchased from Boom BV 
(Meppel, The Netherlands). Methanol Lichrosolv and 
formic acid were obtained from Merck KGaA (Darm-
stadt, Germany). Ammonium formate was obtained from 
Acros Organics (Geel, Belgium). All chemicals were of  
suitable analytical grade. Newborn calf  serum was pur-
chased from Gibco (Thermo Fisher, Life Technologies 
Europe BV, Bleiswijk, The Netherlands). Blank human 
serum was obtained from unpaid, healthy volunteers. Pu-
rified water (sterile water for irrigation) was from Baxter 
(Utrecht, The Netherlands).
Liquid chromatography and mass spectrometric 
conditions 
The liquid chromatography system (Thermo Scientific 
Dionex Ultimate 3000, Waltham, MA, USA) consisted 
of  a binary Ultimate 3000 DGP-3600 RS pump, an on-
line solvent degasser, a temperature-controlled Ultimate 
3000 column compartment, and an Ultimate 3000 au-
tosampler. Chromatographic separation was performed 
on a Thermo Scientific Hypersil Gold PFP 3 μm, 150 x 
2.1 mm column. The column was maintained at 30 °C. 
The flow rate of  the mobile phase was kept at 0.4 mL/
min. The mobile phase consisted of  (A) 2 mM ammoni-
um formate and 0.1% (v/v) formic acid in water and (B) 
0.1% (v/v) formic acid in methanol. The gradient elution 
method was as follows: 5% B at 0-0.5min, 5-95% B at 
0.5-9.0 min, 95% B at 9.0-9.5 min, 95-5% B at 9.5-9.6 
min, and 5% B at 9.6-15 min.
The autosampler temperature was maintained at 10 °C 
and the pressure of  the system was 2600 psi. Detection 
of  the analytes and the internal standard was performed 
on a high-resolution accurate mass Exactive® mass 
spectrometer equipped with an Orbitrap mass analyzer 
(Thermo Scientific, Waltham, MA, USA). The Orbitrap 
mass analyzer is a mass analyzer that traps ions in an or-
bital motion. The image current from the trapped ions 
is detected and converted into a mass spectrum using 
the Fourier transform of  the frequency signal. Source 
dependent parameters for H-ESI II probe were: sheath 
gas pressure: 50 psi; auxiliary gas pressure: 30 psi; ion 
spray voltage: 3000 V; capillary temperature: 350 °C; va-
porizer temperature: 300 °C. The scan parameters for the 
Exactive mass spectrometer were: full mass spectrum; 
microscan:1; resolution: 100,000; target AGC value: 1e6; 
maximum IT: 250 msec; scan range: 100-1000 m/z. MS 
acquisition method:  PRM. Processing method parame-
ters: metoprolol m/z 268.1907 mass tolerance ± 10 ppm; 
α-hydroxymetoprolol m/z 284.1856 mass tolerance ± 10 
ppm; metoprolol-d7 m/z 275.2335 mass tolerance ± 10 
ppm. Xcalibur software version 1.1 SP3 (Thermo Scien-
tific) was used for instrument control, data acquisition 
and processing.
Stock solutions, calibration standards and quality 
control samples 
Stock solutions of  metoprolol (5 mg/L) and α-hy-
droxymetoprolol (5 mg/L) were prepared in methanol. 
From both stock solutions 0,5 mL was diluted to 10.0 
Figure 1. Chemical structures of  metoprolol (A) and α-hy-
droxymetoprolol (B).
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mL with blank calf  serum to yield a working solution 
with a concentration of  250 µg/L for both metoprolol 
and α-hydroxymetoprolol. This solution was used for 
daily preparation of  calibration standards at concentra-
tions of  5.0, 10.0, 30.0, 60.0, 125.0, 185.0, 250.0 µg/L 
for both metoprolol and α-hydroxymetoprolol by di-
luting with blank calf  serum. The quality control sam-
ples were prepared in blank calf  serum at four different 
concentration levels: 5.0, 10.0 (LQ), 125.0 (MQ), 250.0 
µg/L (HQ) for both metoprolol and α-hydroxymetopro-
lol respectively. For determination of  the lower limit of  
quantitation (LLOQ) quality control samples of  0.5, 1.0, 
2.0, 3.0, 4.0 and 5.0 µg/L for both metoprolol and α-hy-
droxymetoprolol were prepared by diluting the working 
standard solution with blank calf  serum. Stock solution 
(10 mg/L) of  the internal standard (IS) was prepared in 
a 10 mL volumetric flask by dilution of  1.00 mL of  me-
toprolol-d7 hydrochloride (100 mg/L in methanol) with 
methanol. Precipitation solution with internal standard 
(0.025mg/L) was prepared in a 200 ml volumetric flask 
by dilution of  500 µL of  stock solution of  metoprolol-d7 
hydrochloride (10 mg/L) with water:acetonitrile (15-85, 
v/v). All the solutions were stored at 2-8 °C and were 
brought to room temperature before use.
Sample preparation
An aliquot of  200 µL of  serum sample was transferred 
into a 5 mL borosilicate glass test tube, and 750 µL of  
precipitation solution with IS was added. The mixture 
was vortexed for 5 sec. Next, the test tube was shaken on 
a Multi Reax shaker (Heidolph Instruments, Schwabach, 
Germany) for 5 min at 1400 rpm. The sample was then 
centrifuged for 5 min at 5000 rpm. An aliquot of  250 
µL of  the clear upper layer was transferred into a clean 
10 mL borosilicate glass test tube. The sample was evap-
orated to dryness in an IR-dancer (Hettlab AG, Bäch, 
Switzerland) for 30 min at 30-35 °C. The residue was re-
constituted with 250 µL of  the mobile phase (A-B 95:5 
(v/v)). The sample was transferred into a pre-labeled au-





The method was validated largely in accordance with the 
EMEA Guideline on bioanalytical method validation 
[16]. The validated criteria included selectivity, linearity, 
accuracy and precision, matrix effects and stability. The 
validation was performed with maximum tolerated bias 
and relative standard deviation (RSD) of  20% for the 
lower limit of  quantitation and 15% for the other validat-
ed concentrations.
Matrix effects
Blank calf  serum was used as surrogate matrix for mak-
ing calibrators and quality control samples. For compar-
ison of  the effect of  surrogate matrix calf  serum vs hu-
man serum on recovery, at each level of  calibration blank 
human serum samples were spiked with metoprolol and 
α-hydroxymetoprolol. Samples were analyzed on a cali-
bration curve obtained from blank calf  serum calibrators. 
Mean recoveries should be within 85-115%. F-test and 
T-test should show no significant difference on recovery 
(p<0.05) between surrogate matrix blank calf  serum and 
blank human serum. 
For the evaluation of  the effects of  human serum 
constituents over the ionization of  metoprolol, α-hy-
droxymetoprolol and IS 6 different lots of  blank human 
serum from individual donors were used. For metopro-
lol, α-hydroxymetoprolol and IS the matrix factor (MF) 
was calculated for each lot of  human serum by calculat-
ing the ratio of  the peak area in the presence of  matrix 
(measured by analyzing blank human serum spiked after 
extraction with analyte), to the peak area in absence of  
matrix (precipitation solution spiked with analyte). The 
IS normalized MF was also calculated by dividing the MF 
of  the analyte by the MF of  the IS. The relative stan-
dard deviation (RSD) of  the IS normalized MF calcu-
lated from the 6 lots of  blank human serum should not 
be greater than 15% [10]. Matrix effect for metoprolol 
and α-hydroxymetoprolol were determined at low and 
high concentrations i.e., 10.0 and 250.0 µg/L, whereas 
the matrix effect over the IS was determined at a single 
concentration of  25.0 µg/L.
Selectivity
The selectivity of  the method was determined by analy-
sis of  blank calf  serum, blank human serum and serum 
from 6 different patients. Every sample was processed 
by the procedure as described in section 2.4. and injected 
into the chromatographic system in order to determine 
the extent of  interference of  endogenous serum compo-
nents at the retention times of  metoprolol, α-hydroxyme-
toprolol and IS. 
Linearity and lower limit of  quantitation
To evaluate linearity, calibration standards of  7 concen-
trations of  metoprolol (5-250 µg/L) and α-hydroxyme-
toprolol (5-250 µg/L) were separately extracted and 
assayed. Three calibration curves were determined at 3 
separate days by different analysts. The linearity of  each 
Stability
Stability experiments were performed to evaluate the 
stability of  metoprolol and α-hydroxymetoprolol during 
sample preparation and sample analysis. To determine 
bench top stability 6 replicates of  each level of  LQ and 
HQ samples were maintained at room temperature in 
daylight or in the dark for 24 h. Then the samples were 
processed and analyzed. Long term stability with storage 
at -24 °C for 0.75 y was determined at LQ, MQ and HQ 
levels for 2 replicates of  each level. Then the samples 
were processed and analyzed. Freeze-thaw stability with 
storage at -24 °C was performed at LQ, MQ and HQ lev-
els using 6 replicates at each level. After the completion 
of  2 freeze-thaw cycles the samples were analyzed. Au-
tosampler stability was performed at LQ and HQ levels 
using 16 replicates at each level and processing 1 sample 
every 2 h for 30 h. For all experiments the concentrations 
of  metoprolol and α-hydroxymetoprolol were compared 
with the nominal values. Mean recovery and recovery in 
comparison with baseline were determined. The mean 




For use in clinical toxicology in our laboratory an ul-
tra-high resolution accurate mass LC/MS assay for fo-
rensic toxicology screening in human serum was slightly 
modified [17]. The time of  the gradient elution meth-
od was reduced to 15 min and sample preparation was 
performed with water-acetonitril 15:85, v/v. This clinical 
toxicology screening method was used for quantitative 
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calibration curve of  metoprolol and α-hydroxymetopr-
olol was determined by plotting the peak area ratios of  
the analyte and IS peaks against concentrations. The cal-
ibration model was selected based on the analysis of  the 
data by linear regression with weighting factors (none, 
1/x, and 1/x2). The quantitation limit is generally deter-
mined by the analysis of  samples with known concentra-
tions of  analyte and by establishing the minimum level 
at which the analyte can be quantified with acceptable 
accuracy and precision. For determination of  LLOQ, 6 
replicates of  quality control samples of  metoprolol and 
α-hydroxymetoprolol in concentrations ranging from 0.5 
to 5.0 µg/L were analyzed against the calibration curve 
at 3 separate days and the obtained concentrations were 
compared with the nominal value. The mean within-run 
and between-run concentrations of  the LLOQ should 
be within 20% of  the nominal value. The within-run and 
between run relative standard deviation (RSD, %) should 
not exceed 20%.
Precision and accuracy
The precision and accuracy of  the method were evalu-
ated by assaying QC samples at 5 concentrations with 6 
replicates for each concentration. Six replicates of  each 
level were analyzed in a day or over 3 separate days by 
different analysts by performing the repeatability of  the 
analysis. Precision was expressed as relative standard 
deviation (RSD, %), and accuracy was expressed as the 
relative error (RE, %) from the nominal value. The devi-
ation in precision value (RSD, %) should be within 15% 
and accuracy (RE, %) should be within 15% from the 
nominal values, except for LLOQ, where it should not 
exceed 20%.
Figure 2. Representative chromatogram for metoprolol (m/z 268.1907) and α-hydroxymetoprolol (m/z 284.1856) in serum with 
metoprolol-d7 (m/z 275.2455) as internal standard.
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(M+H)+ ions at m/z 268.1907, 284.1856 and 275.2455 
respectively in full scan spectra.
Selectivity
The selectivity of  the method was investigated by com-
paring the chromatograms of  blank calf  serum, blank 
human serum and serum from 6 different patients, with 
known concentration spiked blank calf  serum chromato-
grams. No significant interferences from endogenous 
substances in serum were found. In Figure 2 a typical 
determination of  metoprolol and α-hydroxymetoprolol.
Separation and detection
With a total run time of  15.0 min, metoprolol, α-hy-
droxymetoprolol and IS were exhibited at retention times 
of  7.7, 5.9 and 7.7 min respectively. Using water:aceto-
nitrile (15-85, v/v) as a solvent for the precipitation of  
proteins in the sample processing, clean chromatograms 
were obtained with no significant matrix effect. Me-
toprolol, α-hydroxymetoprolol and IS gave protonated 
Figure 3. Chromatogram of  quality control sample (LLOQ) metoprolol 2.0 µg/L.
Table 1. Intra- and interday precision and accuracy for metoprolol and α-hydroxymetoprolol in calf  serum.
Nomimal concentration 
analyte (μg/L)














2.0 2.2 ± 0.2 7.2 5.6 2.1 ± 0.2 7.8 1.9
5.2 5.3 ± 0.2 4.4 2.6 5.2 ± 0.3 6.3 -0.5
10.4 10.2 ± 0.3 2.8 -1.6 10.0 ± 0.3 3.4 -3.8
130.6 127.6 ± 1.1 0.9 -2.3 127.1 ± 1.2 1.0 -2.7
261.1 255.6 ± 4.4 1.7 -2.1 251.1 ± 5.5 2.2 -3.8
α-hydroxymetoprolol
1.0 1.1 ± 0.1 6.9 8.3 1.0 ± 0.1 10.1 1.1
5.0 5.3 ± 0.1 2.8 5.7 5.2 ± 0.3 6.6 3.3
10.0 10.2 ± 0.6 5.4 2.3 10.3 ± 0.6 5.4 2.7
125.0 125.7 ± 6.0 4.8 0.6 125.4 ± 5.6 4.5 0.3
250.0 254.9 ± 11.0 4.3 2.0 248.3 ± 11.8 4.8 -0.7
aStandard deviation; bRelative standard deviation; cRelative error from the nominal value
chromatogram for metoprolol and α-hydroxymetoprolol 
in human serum is shown. 
Linearity, precision and accuracy
The calibration curve was constructed by plotting the 
peak area ratios (y) of  each analyte to that of  the internal 
standard versus the nominal concentration (x) of  each 
analyte. After comparing the weighting factor models at 
none, 1/x and 1/x2, the regression equation with weight-
ing factor 1/x for all analytes was found to be the best 
fit with correlation coefficients (r2) of  0.9990-0.9996 and 
0.9963-0.9991 for metoprolol and α-hydroxymetoprolol, 
respectively. The representative regression equations for 
calibration curves during the validation were y = 0.01052 
x + 0.01728 for metoprolol, and y = 0.00756 x – 0.005723 
for α-hydroxymetoprolol. Calibration curves were linear 
from 5.00 to 250.0 µg/L for both metoprolol and α-hy-
droxymetoprolol. In common analytical methods where 
background noise is present, the limits of  detection and 
quantitation are estimated by evaluation of  S/N ratios. 
However, it is difficult to apply this concept to high-reso-
lution accurate mass data when no noise is observed [18]. 
Rather than defining the LLOQ based on S/N, we deter-
mined the LLOQ by the analysis of  samples with known 
concentrations and by establishing the minimum level at 
which the analytes can be quantified with acceptable ac-
curacy and precision. The LLOQ was found to be 2.0 
µg/L for metoprolol (see Figure 3 for chromatogram) 
and 1.0 µg/L for α-hydroxymetoprolol. Table 1 summa-
rizes the intra- and interday precision and accuracy for 
metoprolol LLOQ (2.0 µg/L) and QC samples at 5.2, 
10.4, 130.6 and 261.1 µg/L, and for α-hydroxymetopro-
lol LLOQ (1.0 µg/L) and QC samples at 5.0, 10.0, 125.0 
and 250.0 µg/L concentrations in calf  serum. Intra- and 














Lot 1L 1.11 1.07 1.04 1.16 1.07 1.08
Lot 2L 1.25 1.14 1.10 1.11 1.14 0.97
Lot 3L 1.14 1.17 1.07 1.23 1.07 1.15
Lot 4L 1.12 1.11 1.01 1.26 1.11 1.14
Lot 5L 0.96 0.92 1.04 0.99 0.92 1.08
Lot 6L 1.17 1.17 1.00 1.24 1.17 1.06
Mean 1.04 1.08
RSDa (%) 3.8 6.5
Blank calf  serum L 1.25 1.20 1.04 1.25 1.20 1.04
Lot 1H 1.29 1.06 1.22 1.13 1.06 1.07
Lot 2H 1.33 1.11 1.20 1.11 1.11 1.00
Lot 3H 1.36 1.10 1.24 1.12 1.10 1.02
Lot 4H 1.28 1.06 1.21 1.08 1.06 1.02
Lot 5H 1.36 1.11 1.23 1.09 1.11 0.98
Lot 6H 1.34 1.06 1.26 1.10 1.06 1.04
Mean 1.22 1.02
RSDa (%) 1.6 2.9
Blank calf  serum H 1.11 0.94 1.18 0.99 0.94 1.05
aRelative standard deviation; MF, matrix factor; IS, internal standard; L, low concentration;  H, high concentration. 
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interday precision (RSD) were measured to be within 
0.9-7.8% for metoprolol, and within 2.8-10.1% for α-hy-
droxymetoprolol. Accuracy (RE) were -3.8-5.6% for me-
toprolol and -0.7-8.3% for α-hydroxymetoprolol.
As in pharmacokinetic studies concentrations of  metop-
rolol and α-hydroxymetoprolol were not to be expected 
higher than the calibration range, dilution integrity was 
not assessed.
Recovery and matrix effect 
Recoveries from QCs in surrogate matrix (blank calf  se-
rum) or pooled human serum were 97.7 (RSD 2.4%) and 
98.3 (RSD 2.6%) for metoprolol, and 103.0 (RSD 4.1%) 
and 103.0 (RSD 4.4%) for α-hydroxymetoprolol, respec-
tively. No significant differences (p<0.05) on recoveries 
were seen between surrogate matrix blank calf  serum 
and blank human serum. 
The ionization can be suppressed and enhanced by 
co-eluting matrix components. Therefore the potential 
variable matrix related ion suppression was evaluated in 
6 independent sources of  human serum by calculating 
the IS normalized matrix factor. For metoprolol the IS 
normalized matrix factor ranged between 1.04 and 1.26 
with an RSD of  <4%; for α-hydroxymetoprolol the IS 
normalized matrix factor ranged between 0.97 and 1.15 
with an RSD of   <7% (Table 2).
Stabilities 
In Table 3 the results from all the stability experiments 
are shown. Metoprolol and α-hydroxymetoprolol in qual-
ity control samples were stable for 24 h at room tem-
perature in daylight as well as in the dark. No significant 
degradation was observed after 2 freeze-thaw cycles and 
during autosampler storage for 30 h. Metoprolol and 
α-hydroxymetoprolol in quality control samples were at 
least stable at -24 °C for 267 days. All results were within 
15% of  the nominal concentrations, showing sufficient 
stability for sample analysis and storage. 
Method application
This method will be applied in clinical studies on the 
influence of  Roux-en-Y gastric bypass surgery on the 
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 with baseline 
(%)
Bench top stability for 24 h 
in daylight
10.4 97.1±3.3 1.8 10.0    97.4±3.7 5.0
261.1 94.7±0.7 -0.7 250.0 102.0±4.1 -2.7
Bench top stability for 24 h 
in the dark
10.4 94.2±2.8 -1.2 10.0    96.1±5.0 -6.3
261.1  94.9±1.2 -0.5 250.0 103.2±2.4 3.9
Long term stability at -24 °C 
for 267 days
10   97.0±1.0 -0.8 10.0    89.0±1.0 -3.3
125 96.8±0.9 -3.2 125.0 96.7±1.4   -1.4
250  96.1±0.3 -0.6 250.0 98.8±4.9 1.2
Freeze-thaw stability at -24 
°C (2 cycles)
10.4   93.0±4.9 -2.3 10.0    97.9±6.7 -1.3
130.6 96.0±1.1  -0.4 125.0 103.2±2.4 1.0
261.1 94.5±1.4 -0.9 250.0 100.6±3.9 1.3
Autosampler stability for 30 h 10.4 100.3±3.5 -4.8 10.0    95.4±6.2 -11.1
261.1 100.1±1.3 -1.3 250.0 96.4±3.0 0.5
SD, standard deviation. 
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rate and extent of  absorption of  metoprolol from dif-
ferent oral formulations (Dutch Trial Register numbers 
NTR4000 and NTR4001). Results will be available short-
ly. Figure 4 shows serum concentrations of  metoprolol 
and α-hydroxymetoprolol after administration of  a me-
toprolol tartrate 100 mg tablet to a patient before surgery.
Conclusion
This validated LC-Orbitrap MS method for the simul-
taneous determination of  metoprolol and α-hydroxyme-
toprolol in human serum was simple, selective, precise, 
accurate and reproducible. Absence of  matrix interfer-
ences effects was adequately demonstrated. This method 
can be used for application in human pharmacokinetics.
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